Sjogren's Syndrome and Multiple Myeloma

By Rodriguez-Cuartero A.   Salas-Galan A.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 167-168

Elsevier

Access to resources Recommend Favorite

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

By Wu Kai-Da   Zhou Li   Burtrum Douglas   Ludwig Dale   Moore Malcolm  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 343-357

Springer Publishing Company

Access to resources Recommend Favorite

Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration

By Terpos Evangelos   Politou Marianna   Rahemtulla Amin  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 623-625

Springer Publishing Company

Access to resources Recommend Favorite

Anti-mitochondrial M2 antibody-positive autoimmune hepatitis

By                

Experimental and Therapeutic Medicine, Vol. 10, Iss. 4, 2015-01 ,pp. : 1419-1422

Spandidos Publications

Access to resources Recommend Favorite

Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen

By Sainz Irma   Isordia-Salas Irma   Espinola Ricardo   Long Walter   Pixley Robin   Colman Robert  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 7, 2006-07 ,pp. : 797-807

Springer Publishing Company

Access to resources Recommend Favorite